Moreover, AML MSCs display constitutive TGFβ signaling, which may be inhibited by the transcription factor FOS upregulation, and secrete lower levels of IL-6 and granulocyte macrophage colony-stimulating factor levels, resulting in diminished supportive capacity for healthy marrow precursors [40]. Here, TGFB1 is linked to acute myeloid leukemia.